Nicardipine

Note: This product is not licenced in Australia the time of publication. The information in this monograph applies to the specified brand, formulation and strength only.

Trade name

Nicardipine Arrow

Presentation and preparation

1 mg/mL (volume: 10 mL)

IV administration

Dilute to 0.1 to 0.2 mg/mL with glucose 5% and give as a slow continuous infusion, preferably via a central line or large peripheral vein using a syringe or infusion pump with DERS.

Maximum concentration if necessary: 0.5 mg/mL via a central line only.

Other routes of administration

IM: Contraindicated.

SC: Contraindicated.

Compatible IV fluids

Glucose 5%

Additional information

Extravasation risk.

Peripheral infusion sites should be changed every 12 hours to minimise irritation.

Use only when facilities for cardiac monitoring and cardio-respiratory resuscitation exist.

Monitor heart rate and blood pressure during and for at least 12 hours after the end of administration.

The solution should be clear and pale yellow.

Protect from light during storage.